February 16, 2016
The Food and Drug Administration could soon approve a complex biosimilar to treat eight disease states and patient groups – even though clinical testing data has been submitted for only two.
February 8, 2016
The Centers for Medicare and Medicaid Services’ billing code system for biosimilars earned it a “D-” grade at the House Energy and Commerce Health Subcommittee’s February 4 hearing on biologics.
February 4, 2016
In a November 2015 notice the Centers for Medicare and Medicaid Services warned that states rationing costly hepatitis C cures may “unreasonably restrict access” for Medicaid patients.
January 28, 2016
After years of international debate, the World Health Organization has issued its final proposal embracing distinct names for biological medicines, including biosimilars.
January 28, 2016
January 26 ended the public comment period for the U.S. Senate Finance Committee’s chronic care working group policy options paper—cueing the group’s legislative efforts to begin in earnest.
January 26, 2016
The U.S. Preventive Services Task Force has issued final guidance on how often and at what age women should receive mammograms to screen for breast cancer.
January 21, 2016
It’s time for clarity about the prescribing information that accompanies biosimilar medications, the U.S. House Doctors Caucus told the FDA in a Dec. 21, 2015 letter.
January 12, 2016
The new year brings tighter laws on childhood vaccinations in several states—many spurred by California’s 2015 measles outbreak and the nationwide public health debate that followed.
January 5, 2016
Medications treating mental illness symptoms in elderly patients have become widely used –sometimes overused – in long-term care facilities.
January 1, 2016
By David Charles, MD and Mary Ann Chapman, PhD More than 2 million elderly Americans live in long-term care settings…
